Development In Proteomics, Genomics And Imaging System Driving The CNS Biomarkers Market

According to a recently published report, the Global Central Nervous System (CNS) Biomarkers Market is expected to grow at the CAGR of 20% during 2015-2022 and it estimated to be $XX billion by 2022. The Global Central Nervous System (CNS) Biomarkers Market is segmented on the basis of application, type, end user and geography. The report on Global Central Nervous System (CNS) Biomarkers Market Forecast 2015-2022 provides detailed overview and predictive analysis of the market.

The Global Central Nervous System (CNS) Biomarkers Market is expected to grow exponentially due to diagnostic development and rise in personalized medicine market. With increasing diagnostic and life style oriented diseases such as Parkinson’s disease, Alzheimer’s disease and so on. Global CNS biomarker market is considered to be potential market due to increase in diagnostics, globally.

Full report available Global Central Nervous System (CNS) Biomarkers Market forecast 2015-2022 report at http://www.briskinsights.com/report/central-nervous-system-biomarker

Global Central Nervous System (CNS) Biomarkers Market is expected to contribute highest in North America followed by Europe. Rise in adoption of Global Central Nervous System (CNS) Biomarkers Market such as biosensors, accelerometers, pressure sensors, temperature sensors, image sensors and so on are major drivers for the Global Central Nervous System (CNS) Biomarkers Market. Abastar MDX Inc, Thermo fisher scientific, Abiant Inc, EKFdiagnostics holdings Inc, Enzo biochem Inc, Acumen pharmaceuticals Inc, Adlyfe Inc, Alseres pharmaceuticals Inc, Apitope international, Aposense, Applied neurosolutions Inc, Avacta group plc, Merc & co. Inc, Avid radiopharmaceuticals Inc, Banyan biomarkers, Diagenic ASA, Exonhit therapeutics, Genenews ltd, Glycominds ltd, Great lakes neurotechnologies, Innogenetics biological, innovative neurotechnologies Inc are the key market players. Mergers and acquisition, partnerships are the key winning strategy of the market.

Scope of the report

1. Global central nervous system(CNS) biomarkers market by application 2012- 2022
1.1. Global diagnostic development market 2012-2022 ($ billion)
1.2. Global personalized medicine market 2012-2022 ($ billion)
1.3. Global disease risk assessment market 2012-2022 ( $ billion)
1.4. Global drug discovery & development Market 2012-2022 ($ billion)
1.5. Global Disease Risk Assessment Market 2012-2022 ($ billion)
1.6. Global Others Market 2012-2022 ($ billion)

2. Global Central Nervous System(CNS) Biomarkers Market by type 2012-2022 ( $ billion)
2.1. Global safety biomarker Market 2012-2022 ($ billion)
2.2. Global efficacy biomarker Market 2012-2022 ($ billion)
2.2.1. Global predictive biomarker Market 2012-2022 ($ billion)
2.2.2. Global surrogate biomarker Market 2012-2022 ($ billion)
2.2.3. Global pharmacodynamics Market 2012-2022 ($ billion)
2.2.4. Global prognostic biomarker Market 2012-2022 ($ billion)
2.3. Global validation biomarker Market 2012-2022 ($ billion)

3. Global Central Nervous System(CNS) Biomarkers Market by end user 2012-2022 ( $ billion)
3.1. Global Hospitals Market 2012-2022 ($ billion)
3.2. Global Eye Clinics Market 2012-2022 ($ billion)
3.3. Global Diagnostics centers Market 2012-2022 ($ billion)
3.4. Global patients Market 2012-2022 ($ billion)
3.5. Global others Market 2012-2022 ($ billion)

4. Global Central Nervous System(CNS) Biomarkers market regional outlook 2012-2022 ( $ billion)
4.1. North America
4.2. Europe
4.3. Asia Pacific
4.4. Middle East & Africa
4.5. Central & South America

5. Competitive Landscape
5.1. ABASTAR MDX INC
5.2. THERMO FISHER SCIENTIFIC
5.3. ABIANT INC
5.4. ENZO BIOCHEM INC
5.5. ACUMEN PHARMACEUTICALS INC
5.6. ADLYFE INC
5.7. ALSERES PHARMACEUTICALS INC
5.8. APITOPE INTERNATIONAL
5.9. APOSENSE
5.10. APPLIED NEUROSOLUTIONS INC
5.11. AVACTA GROUP PLC
5.12. MERC & CO. IN
5.13. AVID RADIOPHARMACEUTICALS INC
5.14. BANYAN BIOMARKERS
5.15. DIAGENIC ASA
5.16. EXONHIT THERAPEUTICS
5.17. GENENEWS LTD
5.18. GLYCOMINDS LTD
5.19. GREAT LAKES NEUROTECHNOLOGIES
5.20. INNOGENETICS BIOLOGICALS